VV
Versant Venture Management, LLC
San Francisco CA · SEC CIK 0001560009
$162.61M2026Q2 reported value
8Positions
100.0%Top 10 weight · largest 47.3%
0 / 0New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
No buys this quarter
2026Q2 top sells estimated at quarter-end value
JBIO Reduced-$11.87M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | $76.97M | 47.34% | 3,180,780 | 0 | 0.0% | — | Unchanged |
| IPSC | Century Therapeutics, Inc. | $29.81M | 18.33% | 12,166,109 | 0 | 0.0% | — | Unchanged |
| JBIO | Jade Biosciences, Inc. | $22.04M | 13.55% | 991,783 | -534,037 | -35.0% | -$11.87M | Reduced |
| LENZ | Lenz Therapeutics, Inc. | $15.09M | 9.28% | 2,656,888 | 0 | 0.0% | — | Unchanged |
| CTNM | Contineum Therapeutics, Inc. | $8.89M | 5.47% | 542,628 | 0 | 0.0% | — | Unchanged |
| CRSP | CRISPR Therapeutics AG | $8.12M | 4.99% | 148,831 | 0 | 0.0% | — | Unchanged |
| — | Skye Bioscience, Inc. | $1.39M | 0.86% | 2,007,704 | 0 | 0.0% | — | Unchanged |
| — | Tempest Therapeutics, Inc. | $299,447 | 0.18% | 269,772 | 0 | 0.0% | — | Unchanged |